Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Debt / NOTE 2.875% 2/1
-
Market price (% of par)
-
105.17%
-
Total 13F principal
-
$250,703,607
-
Principal change
-
+$2,545,880
-
Total reported market value
-
$271,591,541
-
Number of holders
-
19
-
Value change
-
-$2,439,434
-
Number of buys
-
7
-
Number of sells
-
10
Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 as of Q4 2024
As of 31 Dec 2024,
COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$250,703,607
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, WHITEBOX ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, BNP PARIBAS FINANCIAL MARKETS, SILVERBACK ASSET MANAGEMENT LLC, Polar Asset Management Partners Inc., ARISTEIA CAPITAL, L.L.C., WOLVERINE ASSET MANAGEMENT LLC, SSI INVESTMENT MANAGEMENT LLC, and Jump Financial, LLC.
This page lists
19
institutional bondholders reporting positions
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.